港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

922.671

+26.1432.92%

漲家數：11

跌家數：5

平家數：2

市盈率：- -

高：932.797

開：893.740

低：891.998

收：896.528

資料載入中...

總覽新聞資訊

復星醫藥05月09日遭主力拋售208.4萬元

同源康醫藥-B05月09日獲主力加倉917.9萬元

比亞迪電子05月09日遭主力拋售367.2萬元

我國首個國產罕見病特醫食品上市阿里健康罕見病關愛平臺首發

比亞迪“造人”加速：新能源巨頭搶灘人形機器人新賽道

石藥集團(01093)出現大手買入100萬股，成交價$5.72，涉資572萬

阿斯达克财经

第21個阿里日來臨前：CEO吳泳銘呼籲“迴歸初心，重新創業”

歌禮制藥-B：早盤漲 5.55% 肥胖症藥物新進展

【銀河醫藥程培】公司點評丨百濟神州：海外放量超預期，創新管線迎來拐點

中国银河证券研究

開拓藥業-B盤中異動早盤快速上漲5.60%

全球6823家藥企，中國生物製藥管線規模排行第15位

【銀河醫藥程培】行業動態 2025.4丨行業經營持續承壓，創新藥迎來價值重塑

中国银河证券研究

開拓藥業(09939.HK)化妝品原料KT-939啓動全球銷售業務

阿斯达克财经

智通港股解盤 | 特朗普緊急救火刺激美股醫藥股利空消化再度走強

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":922.6707,"timestamp":1747037290222,"preClose":896.528,"halted":0,"volume":639468156,"delay":0,"changeRate":0.02916,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":26.1427,"latestTime":"05-12 16:00:00","open":893.73975,"high":932.79736,"low":891.99774,"amount":5930868565.5,"amplitude":0.045508,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"pbRate":1.585523,"peRate":21.198848,"turnoverRate":0.008452,"increases":11,"decrements":6,"flats":1,"marketCap":634840009216,"floatMarketCap":524045002368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":932.79736,"amplitude":0.045508,"preClose":896.528,"low":891.99774,"pbRate":"1.585523","latestPrice":922.6707,"volume":639468156,"delay":0,"open":893.73975,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":921.416,"twentyDayClose":756.168,"sixtyDayClose":879.539,"secType":"PLATE","market":"HK","turnoverRate":0.008452,"peRate":21.198848,"marketCap":634840009216,"floatMarketCap":524045002368,"timestamp":1747037290222,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":11,"down":5,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534102117","title":"復星醫藥05月09日遭主力拋售208.4萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534102117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534102117?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778532,"startTime":"0","endTime":"0","summary":"05月09日, 复星医药股价跌1.57%，报收13.78元，成交金额3165.9万元，换手率0.42%，振幅1.57%，量比0.48。复星医药今日主力资金净流出208.4万元，上一交易日主力净流出362.9万元。该股近5个交易日下跌1.43%，主力资金累计净流出404.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出351.4万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175423a6d8e98e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175423a6d8e98e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1593","02196","BK1515"],"gpt_icon":0},{"id":"2534794101","title":"同源康醫藥-B05月09日獲主力加倉917.9萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534794101","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534794101?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778528,"startTime":"0","endTime":"0","summary":"05月09日, 同源康医药-B股价涨1.98%，报收30.95元，成交金额1.3亿元，换手率1.18%，振幅4.78%，量比1.26。同源康医药-B今日主力资金净流入917.9万元，上一交易日主力净流入1059.4万元。该股近5个交易日上涨7.09%，主力资金累计净流入2414.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6401.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175157a477f9b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175157a477f9b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1574","BK1161","BK1515"],"gpt_icon":1},{"id":"2534381101","title":"比亞迪電子05月09日遭主力拋售367.2萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534381101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534381101?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778523,"startTime":"0","endTime":"0","summary":"05月09日, 比亚迪电子股价跌1.19%，报收33.35元，成交金额3.5亿元，换手率0.46%，振幅2.96%，量比0.66。比亚迪电子今日主力资金净流出367.2万元，连续3日净流出，上一交易日主力净流出1915.6万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为88.89%，平均跌幅为2.30%。该股近5个交易日上涨3.10%，主力资金累计净流入1555.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.3亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174858a477f8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174858a477f8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1580","LU0348767384.USD","BK1149","BK1540","BK1582","BK1589","LU0348766576.USD","00285","LU0274383008.USD","BK1504","BK1607","BK1515"],"gpt_icon":1},{"id":"2534762122","title":"我國首個國產罕見病特醫食品上市阿里健康罕見病關愛平臺首發","url":"https://stock-news.laohu8.com/highlight/detail?id=2534762122","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534762122?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 15:42","pubTimestamp":1746776520,"startTime":"0","endTime":"0","summary":"我国首个国产罕见病特医食品“特爱丙佳”在阿里健康平台首发，为甲基丙二酸血症和丙酸血症患者提供稳定便捷的特医食品供给，实现了国产罕见病特医食品零的突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050915592294f1845d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050915592294f1845d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1615","BK1591","BK1515","BK1617","BK1502","BK1610","BK1584","BK1571","BK1142","BK1189","00241","BK1247","BK1501","BK1589"],"gpt_icon":0},{"id":"2534412949","title":"比亞迪“造人”加速：新能源巨頭搶灘人形機器人新賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2534412949","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534412949?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 15:10","pubTimestamp":1746774658,"startTime":"0","endTime":"0","summary":"近期， 新能源 汽车领军企业 比亚迪 在人形 机器人 领域的动作频频，引发行业高度关注。这不仅是比亚迪本年度首笔重磅股权投资，更是其在 具身智能 领域迄今最大单笔投资，标志着新能源巨头正式加速布局 人形机器人 赛道。业内人士分析认为，比亚迪在新能源汽车智能化竞争中抢滩人形机器人赛道，不仅为汽车业务拓展了技术边界，更在智能制造、工业协作等领域开辟了全新增长曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509151827a6d8b899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509151827a6d8b899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0509642566.USD","002594","LU0289961442.SGD","LU0054450605.USD","81211","LU2097828557.USD","SG9999015952.SGD","BK1515","LU0543330566.HKD","LU1794554557.SGD","LU2097828714.EUR","HYDD.SI","BYDDY","LU0307460666.USD","LU0516422952.EUR","SG9999015986.USD","LU0326950275.SGD","LU0979878070.USD","LU1719994722.HKD","LU0052750758.USD","BK1504","LU0175139822.USD","LU2097828631.EUR","BK1540","SG9999014674.SGD","LU1023057109.AUD","LU0650527681.SGD","01211","LU1251922891.USD","LU0572944931.SGD","BK1589","LU2399975544.HKD","LU0505663152.USD","BK1594","LU2097828805.USD","LU0274383008.USD","BK1580","LU0871576103.HKD","LU0320764599.SGD","LU0708995583.HKD","LU0634319403.HKD","LU0417516738.SGD","LU0588545730.USD","LU0084288322.USD","LU0516423174.USD","LU0823414478.USD","LU0348805143.USD","SG9999015945.SGD","LU2476274308.USD"],"gpt_icon":1},{"id":"2534254721","title":"石藥集團(01093)出現大手買入100萬股，成交價$5.72，涉資572萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2534254721","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534254721?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 14:43","pubTimestamp":1746772980,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在下午02:43出现大手买入，成交量为100万，成交价为港币$5.72，涉资572万。至目前为止，股价跌0.522%，今日最高价为$5.85，而最低价为$5.63，总成交量为7.025千万股，总成交金额港币$4.02亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505096534/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0072913022.USD","LU0326950275.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","BK1515","LU1226288253.USD","LU1226287529.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","IE00B031HY20.USD","IE0008369823.USD","LU1152091168.USD","IE00B543WZ88.USD","LU0067412154.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU1951186391.HKD","01093","BK1191","LU1152091754.HKD","LU1226288170.HKD","LU0140636845.USD","LU1993786604.SGD","LU0880133367.SGD","LU1807302812.USD","LU0501845795.SGD","IE0008368742.USD","LU1008478684.HKD","BK1521"],"gpt_icon":0},{"id":"2534314676","title":"第21個阿里日來臨前：CEO吳泳銘呼籲“迴歸初心，重新創業”","url":"https://stock-news.laohu8.com/highlight/detail?id=2534314676","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534314676?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 12:43","pubTimestamp":1746765810,"startTime":"0","endTime":"0","summary":"5月9日，在第21个510阿里日来临前，阿里巴巴（09988）CEO吴泳铭通过内网发布题为《回归初心重新创业》的全员信，宣布集团将开启新一轮战略调整，强调以创业心态应对AI技术革命带来的机遇与挑战，并透露集团将聚焦“几大核心战役”，由多业务协同推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a6875d334c762277962dfcbf957973c6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505093400502156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1880383366.USD","LU1267930227.SGD","BK4527","BK4531","BK1589","LU0251143458.SGD","LU1048596156.SGD","BK1515","LU0880133367.SGD","LU1152091168.USD","LU0067412154.USD","IE00BFMHRM44.USD","LU0128525689.USD","LU1242518857.USD","LU1515016050.SGD","BK1610","LU1282648689.USD","BABA","BK1571","LU1105468828.SGD","BK4554","BK4505","BK4585","IE00B0JY6N72.USD","LU1008478684.HKD","LU1688375341.USD","LU1051768304.USD","BK4503","BK4504","LU0651946864.USD","LU1051769294.HKD","BK4607","LU0047713382.USD","LU1048588211.SGD","09988","BK4588","LU0310800965.SGD","LU0979878070.USD","BK4220","LU0918141887.USD","BK4526","LU1823568750.SGD","BK4122","BK4565","LU0348816934.USD","BK4524","BK1142","LU0052756011.USD","LU0821914370.USD","00241"],"gpt_icon":1},{"id":"2534771114","title":"歌禮制藥-B：早盤漲 5.55% 肥胖症藥物新進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2534771114","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534771114?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 10:36","pubTimestamp":1746758205,"startTime":"0","endTime":"0","summary":"【歌礼制药-B 早盘上涨 5.55% 现报 7.04 港元 成交额 946.35 万港元】歌礼制药近日称将在西班牙马拉加举行的第 32 届欧洲肥胖症大会上，以口头和壁报形式报告肥胖症候选药物 ASC47 的早期研究。ASC47 是歌礼自主研发的、脂肪靶向、超长效皮下注射选择性小分子激动剂。美国食品药品监督管理局已批准 ASC47 与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050910471694f13969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050910471694f13969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01672","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"2534063142","title":"【銀河醫藥程培】公司點評丨百濟神州 ：海外放量超預期，創新管線迎來拐點","url":"https://stock-news.laohu8.com/highlight/detail?id=2534063142","media":"中国银河证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534063142?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 09:54","pubTimestamp":1746755699,"startTime":"0","endTime":"0","summary":"核心产品海外放量超预期，25年指引经营性现金流转正。2024年全年公司营业收入同比增长56.19%，归母净亏损同比收窄25.87%，主要系核心产品泽布替尼海外持续商业化放量。多项自主研发管线迎来价值拐点。投资建议百济神州作为聚焦创新药研发生产和全球商业化的龙头企业，其核心产品具备同类最佳特质，血液瘤领导地位进一步巩固，多项自主研发管线即将迎来价值拐点。公司评级推荐：相对基准指数涨幅20%以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509135012a477b25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509135012a477b25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","ONC","LU1969619763.USD","LU0588546209.SGD","BK1161","06160","BK1588","BK1574","BK1583","688235","LU2328871848.SGD","LU0307460666.USD","BK1500","BK1515"],"gpt_icon":0},{"id":"2534118275","title":"開拓藥業-B盤中異動 早盤快速上漲5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534118275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534118275?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 09:31","pubTimestamp":1746754290,"startTime":"0","endTime":"0","summary":"2025年05月09日早盘09时31分，开拓药业-B股票出现异动，股价快速上涨5.60%。截至发稿，该股报1.320港元/股，成交量18.75万股，换手率0.04%，振幅3.20%。开拓药业-B股票所在的药品行业中，整体涨幅为0.06%。其相关个股中，开拓药业-B、远大医药、三生制药涨幅较大，振幅较大的相关个股有君圣泰医药-B、三生制药、开拓药业-B，振幅分别为7.30%、3.29%、3.20%。开拓药业-B公司简介：开拓药业有限公司是临床阶段新药开发商。该公司在皮科领域有两款核心药物KX-826及GT20029。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050909313094f1224a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050909313094f1224a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2534118481","title":"全球6823家藥企，中國生物製藥管線規模排行第15位","url":"https://stock-news.laohu8.com/highlight/detail?id=2534118481","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534118481?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 09:28","pubTimestamp":1746754080,"startTime":"0","endTime":"0","summary":"中国生物制药在全球药企管线规模排名中位列第15，新药研发成果显著，2024年营收超288亿元人民币，创新药收入达到120.6亿元。公司将在2025年ASCO大会上披露40多项临床研究数据，展示其创新实力，并通过持续的创新药研发，争夺全球市场份额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050909301894f121e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050909301894f121e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","BK1191","BK1521","BK1589","BK1515"],"gpt_icon":0},{"id":"2534480072","title":"【銀河醫藥程培】行業動態 2025.4丨行業經營持續承壓，創新藥迎來價值重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480072","media":"中国银河证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534480072?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 07:45","pubTimestamp":1746747926,"startTime":"0","endTime":"0","summary":"核心观点医药行业持续调整，医保控费导致业绩承压。全年行业收入基本持平，利润为负增长，主要系宏观经济环境变化叠加医保控费压力加大，医药行业整体经营承压，2025年一季度行业仍位于调整周期。创新药行业扭亏加速，多重利好驱动价值回归。截至2025 年5月6日，医药行业一年滚动市盈率为32.35倍，沪深300为12.30倍。2023年初至2025年5月6日，SW医药生物指数下跌19.37%，沪深300下跌1.63%，医药板块相对沪深300收益低17.74个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509075914a4775a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509075914a4775a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","LU2328871848.SGD","01801","BK1583","BK1574","BK1589","06978","LU2488822045.USD","02359","BK1515","LU1969619763.USD","09926","02269"],"gpt_icon":0},{"id":"2533158414","title":"開拓藥業(09939.HK)化妝品原料KT-939啓動全球銷售業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2533158414","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533158414?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 23:29","pubTimestamp":1746718140,"startTime":"0","endTime":"0","summary":"开拓药业－Ｂ(09939.HK) 公布，自主研发的具有美白祛斑功能的功效性化妆品原料KT-939正式启动全球销售业务，并于近期成功完成首份原料销售，标志公司正式进军功效性化妆品原料领域。KT-939为公司所开发的一种酪氨酸酶抑制剂，可高效抑制黑色素生成，兼具抗氧化和抗炎作用。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220721143637635_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220721143637635_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1438723/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"2533133727","title":"智通港股解盤 | 特朗普緊急救火刺激美股 醫藥股利空消化再度走強","url":"https://stock-news.laohu8.com/highlight/detail?id=2533133727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533133727?lang=zh_tw&edition=fundamental","pubTime":"2025-05-08 21:20","pubTimestamp":1746710421,"startTime":"0","endTime":"0","summary":"据知情人士透露，特朗普政府计划撤销拜登时代的人工智能芯片限制，这些限制遭到了主要科技公司和外国政府的强烈反对。说一下医药股，5 月 5 日，美国总统特朗普签署了一项旨在促进国内药品生产的行政命令，并警告称，他将在未来两周内对该行业征收进口关税。受此影响，5 月 7 日港股医药板块大幅下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4614","601633","GWLLY","01057","HSCEI","BK1539","159938","BK1144","BK1161","01274","HSTECH","YANG","BK1119","82333","BK1515","09939","BK1574","02333"],"gpt_icon":1}],"pageSize":20,"totalPage":18,"pageCount":5,"totalSize":347,"code":"91000000","status":"200"}]}}